Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Voyageur Pharmaceuticals Ltd VYYRF


Primary Symbol: V.VM

Healthcare Drug Manufacturers - Specialty & Generic
Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

Recent & Breaking News (TSXV:VM)

Voyageur Pharmaceuticals Ltd. Announces Final Closing of Increased Private Placement

TheNewsWire January 20, 2023

Voyageur Pharmaceuticals (TSXV:VM) upsizes non-brokered private placement

John Ballem  January 13, 2023

Voyageur Pharmaceuticals Ltd. Announces Increase to Private Placement

TheNewsWire January 12, 2023

Voyageur Pharmaceuticals (TSXV:VM) closes first tranche of private placement

Trevor Abes  December 23, 2022

Junior biotech company poised for MAJOR pharma success

Jeff Nielson December 23, 2022

Voyageur Pharmaceuticals Ltd. Announces First Closing of Private Placement

TheNewsWire December 23, 2022

Voyageur Pharmaceuticals (TSXV:VM) introduces SmoothX and announces capital raise

John Ballem  December 12, 2022

Voyageur Pharmaceuticals Ltd. Announces Canadian Launch of SmoothX (TM) Barium Contrast Media & Financing

TheNewsWire December 8, 2022

Voyageur Pharmaceuticals Ltd. Announces Equity Incentive Compensation

Newsfile December 2, 2022

Voyageur (TSXV:VM) completes SmoothX testing

Caroline Egan  November 29, 2022

Voyageur Pharmaceuticals Ltd. Completes Medical Imaging CT Contrast Agent Production Testing and Begins Production Scale-up of SmoothX (TM)

TheNewsWire November 28, 2022

Voyageur announces carbon-capture strategy and upgrade to supply chain

Jeff Nielson November 8, 2022

Voyageur Pharmaceuticals (TSXV:VM) designs carbon neutral pharmaceutical manufacturing plant

John Ballem  November 1, 2022

Voyageur Pharmaceuticals Ltd. Designs Carbon Neutral Pharmaceutical Manufacturing Plant with a Carbon Credit De-Carbonization Strategy for Customers

TheNewsWire October 31, 2022

Voyageur (TSXV:VM) and Rain Cage Carbon to develop fullerene contrast agents

Trevor Abes  October 24, 2022

Voyageur Pharmaceuticals Ltd. Signs an MOU for the Development of Carbon Fullerene Contrast Agents for Medical Imaging Applications and Related Carbon Capture Technology

TheNewsWire October 24, 2022

Voyageur Pharmaceuticals Ltd. Submits Notice of Work to Extract 2,000 Tonnes of Barium Sulfate from Frances Creek Project

TheNewsWire September 22, 2022

Biotech company perfectly positioned for the New Economy

Jeff Nielson August 24, 2022

Voyageur Pharmaceuticals Ltd. Announces Resignation of CFO and Appointment of Interim CFO and Shares for Debt Transaction

TheNewsWire August 15, 2022

Voyageur Pharmaceuticals Ltd. Announces Closing of Over Subscribed $1Million Private Placement and Issuance of Shares for Debt

TheNewsWire June 16, 2022